Zacks' proprietary data indicates that Ovid Therapeutics is currently rated as a Zacks Rank 2 and we are expecting an above average return from the OVID shares relative to the market in the next few months. The financial health and growth prospects of OVID, demonstrate its potential to underperform the market.
Will OVID stock go up?
On average, they expect Ovid Therapeutics' share price to reach $4.50 in the next year. This suggests a possible upside of 45.2% from the stock's current price.
Is OVID a dividend stock?
Ovid Therapeutics' common stock is traded on the NASDAQ Global Select Market under the symbol “OVID”. Currently, Ovid Therapeutics does not pay a dividend or offer a dividend reinvestment program.
Is Sdrlf a good stock to buy?
Our Ai stock analyst implies that there will be a negative trend in the future and the SDRLF shares are not a good investment for making money. Since this share has a negative outlook we recommend looking for other projects instead to build a portfolio.
Is OVID stock a good buy?
Zacks' proprietary data indicates that Ovid Therapeutics is currently rated as a Zacks Rank 2 and we are expecting an above average return from the OVID shares relative to the market in the next few months.
Is OVID a good long term stock?
Historical index on US Stock Market : C "Should I invest in Ovid Therapeutics stock?" "Should I trade "OVID" stock today?" According to our live Forecast System, Ovid Therapeutics Inc stock is a bad long-term (1-year) investment*.
Is Ovid a good stock to buy?
Ovid Therapeutics has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 5 hold ratings, and no sell ratings.
Does BYND pay dividends?
BYND does not currently pay a dividend.
What does Ovid Therapeutics do?
About Ovid Therapeutics Inc (Ovid) is a biopharmaceutical company focused on developing medicines for patients and families living with rare neurological disorders. The Company's product pipeline includes two late-stage programs and several early-stage programs.
What is OVID software?
Ovid® Synthesis Clinical Evidence Manager is an easy-to-use, cloud-based application with unparalleled literature search and review capabilities. It's the only solution offering a single, cohesive view of all quality improvement (QI) evidence-based (EBP) and research projects across an organization.
Is OVID a search engine?
Ovid, which is a search engine, can access many common databases including MEDLINE and EMBASE. Although Ovid-accessible databases share the same search interface, they have their own unique MeSH terms.